WEBSITECHANGES

Website Changes

---

10/19/2008

HR 7153: The National Childhood Brain Tumor Prevention Network Act

---

10/19/2008

IBTA E-NEWSLETTER 15 October 2008

---

10/19/2008

Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3

---

10/19/2008

Local tennis: Swingtime announces Super Bowl tickets drawing

---

10/17/2008

Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research

---

10/17/2008

The chances of developing a malignant tumour are “significantly increased” for people who use a mobile for ten years.

---

10/17/2008

Experience with irinotecan for the treatment of malignant glioma

---

10/17/2008

Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases

---

10/17/2008

Monmouth Medical Center art exhibit features original artwork created by kids and teens affected by a loved one’s brain tumor

---

10/09/2008

Free tickets to NY Islanders and Virtualtrials.com is moving!

---

10/08/2008

Target Acquired: It may become possible to vaccinate against brain tumours

---

10/06/2008

Urbana quilt project raises money for brain cancer research

---

10/06/2008

UCSF surgeon changes study of brain tumors

---

10/04/2008

Proton Radiation Appears to Lower Risk for Secondary Cancers

---

10/04/2008

Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.

---

10/04/2008

Prospective phase II trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (LRF) hyperthermia.

---

10/04/2008

A phase II trial with cetuximab, bevacizumab, and irinotecan for patients with primary glioblastomas and progression after radiation therapy and temozolamide.

---

10/04/2008

Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)

---

10/04/2008

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.

---

10/04/2008

A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).

---

10/04/2008

Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.

---

10/04/2008

Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM).

---

10/04/2008

Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas.

---

10/04/2008

Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.

---

10/04/2008

A retrospective single institutional analysis of bevacizumab and chemotherapy versus non-bevacizumab treatments for recurrent glioblastoma.

---